These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 38620799)

  • 41. Glycemic Dysregulation, Inflammation and Disease Outcomes in Patients Hospitalized with COVID-19: Beyond Diabetes and Obesity.
    Liontos A; Biros D; Kavakli A; Matzaras R; Tsiakas I; Athanasiou L; Samanidou V; Konstantopoulou R; Vagias I; Panteli A; Pappa C; Kolios NG; Nasiou M; Pargana E; Milionis H; Christaki E
    Viruses; 2023 Jun; 15(7):. PubMed ID: 37515156
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Obesity, vitamin D deficiency and old age a serious combination with respect to coronavirus disease-2019 severity and outcome.
    Biesalski HK
    Curr Opin Clin Nutr Metab Care; 2021 Jan; 24(1):18-24. PubMed ID: 32941186
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dysregulated Inflammation During Obesity: Driving Disease Severity in Influenza Virus and SARS-CoV-2 Infections.
    Hulme KD; Noye EC; Short KR; Labzin LI
    Front Immunol; 2021; 12():770066. PubMed ID: 34777390
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Risk Factors for COVID-19: Diabetes, Hypertension, and Obesity.
    Buscemi S; Corleo D; Randazzo C
    Adv Exp Med Biol; 2021; 1353():115-129. PubMed ID: 35137371
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Obesity and severe coronavirus disease 2019: molecular mechanisms, paths forward, and therapeutic opportunities.
    Yan T; Xiao R; Wang N; Shang R; Lin G
    Theranostics; 2021; 11(17):8234-8253. PubMed ID: 34373739
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Weight stigma in the COVID-19 pandemic: a scoping review.
    de Macêdo PFC; Nepomuceno CMM; Dos Santos NS; Queiroz VAO; Pereira EM; Leal LDC; Santos LADS; Nascimento LF; Martins PC; de Santana MLP
    J Eat Disord; 2022 Mar; 10(1):44. PubMed ID: 35351201
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Proper Management of People with Obesity during the COVID-19 Pandemic.
    Lim S; Shin SM; Nam GE; Jung CH; Koo BK
    J Obes Metab Syndr; 2020 Jun; 29(2):84-98. PubMed ID: 32544885
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Impact of the COVID-19 Pandemic on Childhood Obesity: A Review.
    Ferentinou E; Koutelekos I; Pappa D; Manthou P; Dafogianni C
    Cureus; 2023 Sep; 15(9):e45470. PubMed ID: 37859918
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Obesity considerations during the COVID-19 outbreak.
    Dohet F; Loap S; Menzel A; Iddir M; Dadoun F; Bohn T; Samouda H
    Int J Vitam Nutr Res; 2022 Jan; 92(1):67-79. PubMed ID: 33499680
    [No Abstract]   [Full Text] [Related]  

  • 50. Overview of the cardio-metabolic impact of the COVID-19 pandemic.
    Barkhordarian M; Behbood A; Ranjbar M; Rahimian Z; Prasad A
    Endocrine; 2023 Jun; 80(3):477-490. PubMed ID: 37103684
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Obesity in patients with COVID-19: a systematic review and meta-analysis.
    Huang Y; Lu Y; Huang YM; Wang M; Ling W; Sui Y; Zhao HL
    Metabolism; 2020 Dec; 113():154378. PubMed ID: 33002478
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Obesity: A Risk Factor for COVID-19.
    Srivastava S; Rathor R; Singh S; Kumar B; Suryakumar G
    Adv Exp Med Biol; 2021; 1352():195-210. PubMed ID: 35132602
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Vitamin D deficiency as a predictor of poor prognosis in patients with acute respiratory failure due to COVID-19.
    Carpagnano GE; Di Lecce V; Quaranta VN; Zito A; Buonamico E; Capozza E; Palumbo A; Di Gioia G; Valerio VN; Resta O
    J Endocrinol Invest; 2021 Apr; 44(4):765-771. PubMed ID: 32772324
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of COVID-19 pandemic on obesity among adults in Jordan.
    Rababah T; Al-U'datt M; Angor MM; Gammoh S; Rababah R; Magableh G; Almajwal A; Al-Rayyan Y; Al-Rayyan N
    Front Nutr; 2023; 10():1114076. PubMed ID: 36742426
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Obesity and COVID-19: what makes obese host so vulnerable?
    Mohammad S; Aziz R; Al Mahri S; Malik SS; Haji E; Khan AH; Khatlani TS; Bouchama A
    Immun Ageing; 2021 Jan; 18(1):1. PubMed ID: 33390183
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Centrality of Obesity in the Course of Severe COVID-19.
    Liu D; Zhang T; Wang Y; Xia L
    Front Endocrinol (Lausanne); 2021; 12():620566. PubMed ID: 33776917
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Obesity and COVID-19 Pandemics: Epidemiology, Mechanisms, and Management.
    Yang Y; Song Y; Hou D
    Diabetes Metab Syndr Obes; 2023; 16():4147-4156. PubMed ID: 38145256
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inflammation and oxidative stress, the links between obesity and COVID-19: a narrative review.
    Moreno-Fernandez J; Ochoa J; Ojeda ML; Nogales F; Carreras O; Díaz-Castro J
    J Physiol Biochem; 2022 Aug; 78(3):581-591. PubMed ID: 35316507
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Janus kinase inhibitors for the treatment of COVID-19.
    Kramer A; Prinz C; Fichtner F; Fischer AL; Thieme V; Grundeis F; Spagl M; Seeber C; Piechotta V; Metzendorf MI; Golinski M; Moerer O; Stephani C; Mikolajewska A; Kluge S; Stegemann M; Laudi S; Skoetz N
    Cochrane Database Syst Rev; 2022 Jun; 6(6):CD015209. PubMed ID: 35695334
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Potential pathophysiological mechanisms leading to increased COVID-19 susceptibility and severity in obesity.
    Belančić A; Kresović A; Rački V
    Obes Med; 2020 Sep; 19():100259. PubMed ID: 32501427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.